225 related articles for article (PubMed ID: 31407723)
21. Impaired insulin secretion in non-diabetic offspring of probands with latent autoimmune diabetes mellitus in adults.
Vauhkonen I; Niskanen L; Knip M; Ilonen J; Vanninen E; Kainulainen S; Uusitupa M; Laakso M
Diabetologia; 2000 Jan; 43(1):69-78. PubMed ID: 10663218
[TBL] [Abstract][Full Text] [Related]
22. Latent Autoimmune Diabetes in Adults in North Indian Region: Assessment of β-Cell Function, Metabolic and Immunological Features.
Kumar A; de Leiva A
Metab Syndr Relat Disord; 2017 Dec; 15(10):494-499. PubMed ID: 29040050
[TBL] [Abstract][Full Text] [Related]
23. Common autoimmune biomarkers, thyroid hormonal abnormalities, and beta cells dysfunction in patients with latent autoimmune diabetes in adults with type II diabetes mellitus.
Yousefzadeh G; Gozashti M; Najafipour H; Gholamhosseinian NA; Bahramnejad A; Shokouhi M
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S52-5. PubMed ID: 27094870
[TBL] [Abstract][Full Text] [Related]
24. Latent Autoimmune Diabetes of Adults (LADA) Is Likely to Represent a Mixed Population of Autoimmune (Type 1) and Nonautoimmune (Type 2) Diabetes.
Jones AG; McDonald TJ; Shields BM; Hagopian W; Hattersley AT
Diabetes Care; 2021 Jun; 44(6):1243-1251. PubMed ID: 34016607
[TBL] [Abstract][Full Text] [Related]
25. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency.
Zimmet PZ; Tuomi T; Mackay IR; Rowley MJ; Knowles W; Cohen M; Lang DA
Diabet Med; 1994 Apr; 11(3):299-303. PubMed ID: 8033530
[TBL] [Abstract][Full Text] [Related]
26. Latent autoimmune diabetes in adults (LADA) is dead: long live autoimmune diabetes!
Rolandsson O; Palmer JP
Diabetologia; 2010 Jul; 53(7):1250-3. PubMed ID: 20336277
[No Abstract] [Full Text] [Related]
27. Clinical utility of measuring both glutamic acid decarboxylase antibodies and islet cell antibodies in the diagnosis of latent autoimmune diabetes in adults - is it cost-effective?
Hughes LE; Ford C; Ekbote A; Gama R
Ann Clin Biochem; 2017 Sep; 54(5):623-624. PubMed ID: 28490183
[No Abstract] [Full Text] [Related]
28. Associated autoimmunity in Type 1 Diabetes and latent autoimmune diabetes of adults: The role of glutamic-acid decarboxylase autoantibodies.
Gougourelas D; Tsentidis C; Koufadaki AM; Koutsovasilis A; Gougourela E; Karanasios S; Sotiropoulos A; Bousboulas S; Karavanaki KA
Diabetes Res Clin Pract; 2021 May; 175():108847. PubMed ID: 33945840
[TBL] [Abstract][Full Text] [Related]
29. Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up.
Huang G; Yin M; Xiang Y; Li X; Shen W; Luo S; Lin J; Xie Z; Zheng P; Zhou Z
Diabetes Metab Res Rev; 2016 Sep; 32(6):615-22. PubMed ID: 26787598
[TBL] [Abstract][Full Text] [Related]
30. Peripheral blood mononuclear cells of patients with latent autoimmune diabetes secrete higher levels of pro- & anti-inflammatory cytokines compared to those with type-1 diabetes mellitus following
Badal D; Kumar R; Paul M; Dayal D; Bhansali A; Bhadada SK; Kumar R; Sachdeva N
Indian J Med Res; 2017 Jun; 145(6):767-776. PubMed ID: 29067979
[TBL] [Abstract][Full Text] [Related]
31. A Global Perspective of Latent Autoimmune Diabetes in Adults.
Mishra R; Hodge KM; Cousminer DL; Leslie RD; Grant SFA
Trends Endocrinol Metab; 2018 Sep; 29(9):638-650. PubMed ID: 30041834
[TBL] [Abstract][Full Text] [Related]
32. Latent autoimmune diabetes of adulthood. Unique features that distinguish it from types 1 and 2.
Nabhan F; Emanuele MA; Emanuele N
Postgrad Med; 2005 Mar; 117(3):7-12. PubMed ID: 15782668
[TBL] [Abstract][Full Text] [Related]
33. Low C-peptide together with a high glutamic acid decarboxylase autoantibody level predicts progression to insulin dependence in latent autoimmune diabetes in adults: The HUNT study.
Sørgjerd EP; Åsvold BO; Grill V
Diabetes Obes Metab; 2021 Nov; 23(11):2539-2550. PubMed ID: 34318969
[TBL] [Abstract][Full Text] [Related]
34. Latent Autoimmune Diabetes in Adults: A Review of Clinically Relevant Issues.
Hernández M; Mauricio D
Adv Exp Med Biol; 2021; 1307():29-41. PubMed ID: 32424495
[TBL] [Abstract][Full Text] [Related]
35. [Type LADA diabetes--interrogation points].
Otto-Buczkowska E
Przegl Lek; 2013; 70(1):25-7. PubMed ID: 23789301
[TBL] [Abstract][Full Text] [Related]
36. The role of C-peptide levels in screening for latent autoimmune diabetes in adults.
Bell DS; Ovalle F
Am J Ther; 2004; 11(4):308-11. PubMed ID: 15266224
[TBL] [Abstract][Full Text] [Related]
37. [Latent autoimmune diabetes in adults: an update].
Zhou ZG; Li X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):630-4. PubMed ID: 14650175
[TBL] [Abstract][Full Text] [Related]
38. A monoclonal antibody-based characterization of autoantibodies against glutamic acid decarboxylase in adults with latent autoimmune diabetes.
Ziegler B; Strebelow M; Rjasanowski I; Schlosser M; Ziegler M
Autoimmunity; 1998; 28(2):61-8. PubMed ID: 9771977
[TBL] [Abstract][Full Text] [Related]
39. Newly diagnosed latent autoimmune diabetes in adults (LADA) is associated with low level glutamate decarboxylase (GAD65) and IA-2 autoantibodies. Diabetes Incidence Study in Sweden (DISS).
Schranz DB; Bekris L; Landin-Olsson M; Törn C; Niläng A; Toll A; Sjöström J; Grönlund H; Lernmark A
Horm Metab Res; 2000 Apr; 32(4):133-8. PubMed ID: 10824708
[TBL] [Abstract][Full Text] [Related]
40. [Latent autoimmune (Type-1) diabetes mellitus in adults. Part. I. Serologic markers of autoimmune involvement of pancreatic beta-cells: GADA, ICA, IA-2 a IA-A].
Martinka E; Ocenásová A; Straková J; Mokán M
Vnitr Lek; 1999 Feb; 45(2):97-102. PubMed ID: 15641228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
